Bristol-Myers Squibb Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 3,707.0 | 3,153.0 | 2,083.0 |
| Net Investing Cash Flow | 5,079.0 | (202.0) | 206.0 |
| Net Financing Cash Flow | (2,582.0) | (3,213.0) | (3,351.0) |
| Net Change in Cash | 6,175.0 | (217.0) | (1,032.0) |
| Depreciation & Amortization | 816.0 | 892.0 | 927.0 |
| Capital Expenditures | (941.0) | (843.0) | (785.0) |
| Cash Dividends Paid | (2,461.0) | (2,213.0) | (2,199.0) |
© 2009 Morningstar, Inc. Financial Data provided by
